SCHEMBL18832657

SCHEMBL18832657

CSc1ccc(C(=O)NC2(OC(=O)O)Cc3ccccc3C2)cc1OCCc1cccc(C)c1

nearest known ligand 0.79

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LPAR1 Q92633 5/20 0.79
▸ GPR132 Q9UNW8 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SIRT2 Q8IXJ6 1/20 0.34
▸ NR1H4 Q96RI1 2/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ MAOB P27338 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ NOX1 Q9Y5S8 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ FAAH O00519 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18832654 0.88 LPAR1 (0.63) LPAR1NPC1RAB9ANOX1
SCHEMBL1561172 0.88 LPAR1 (1.00) LPAR1GPR132
SCHEMBL18832675 0.88 LPAR1 (0.61) LPAR1GPR132NPC1RAB9ASIRT2
SCHEMBL18832662 0.87 LPAR1 (0.60) LPAR1GPR132NPC1RAB9ASIRT2
SCHEMBL18832661 0.87 LPAR1 (0.60) LPAR1MAPT
SCHEMBL18832658 0.86 LPAR1 (0.58) LPAR1GPR132NPC1RAB9ANR1H4
SCHEMBL18832664 0.86 LPAR1 (0.58) LPAR1GPR132NPC1RAB9ASIRT2
SCHEMBL1561438 0.85 LPAR1 (0.85) LPAR1GPR132NPC1RAB9ASIRT2
SCHEMBL18832656 0.82 LPAR1 (0.54) LPAR1GPR132SIRT2F10NOX1
SCHEMBL18832678 0.82 LPAR1 (0.63) LPAR1NPC1RAB9ANOX1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2303270-B1 ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS SANOFI SA (FR) 2017-05-17 — — EP claimed
Send feedback